Advertisement
Product › Details
FluidFM® technology
Next higher product group | cell analysis technology | |
Status | 2018-02-01 sales existent | |
Organisation | Cytosurge AG | |
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications".
Cytosurge and Lab Automation Network (LAN) enter into a strategic partnership to offer automated cell-based solutions for pharmaceutical and biotech applications.
Cytosurge is the leading technology provider for automated single-cell biology. With its FluidFM BOT, Cytosurge offers automated tools for the injection of drug candidates and nucleic acids into single mammalian cells. Lab Automation Network is an alliance of technologically leading solution providers in the field of laboratory automation. Together with its partners, LAN creates high-performance, integrated, high-quality laboratory automation solutions, tailored to the specific needs of its customers.
"This partnership opens up completely new possibilites to speed up workflows in pharmaceutical drug development and cell line development" says Martin Winter, Managing Director of Lab Automation Network.
Alexander Serre, Sales & Marketing Director of Cytosurge, is convinced that joining forces with the other technology leaders in the network "will bring symbiotic win-win solutions for all partners and for our demanding customers".
More Information [ https://www.cytosurge.com/de_DE/partners/lab-automation-network-2949?country_id=58 ]
Record changed: 2023-07-10 |
Advertisement
More documents for FluidFM® technology
- [1] Cytosurge AG. (3/30/22). "Press Release: Cytosurge Launches Cell Line Engineering Services Based on Proprietary FluidFM Technology". Zurich....
- [2] Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich....
- [3] Cytosurge AG. (8/26/20). "Press Release: Cytosurge Announces Appointment of Thomas Bachmann to Board of Directors". Zurich....
- [4] Cytosurge AG. (8/21/19). "Press Release: Cytosurge AG Announces Spin-off of Its 3D Printing Business Unit". Glattbrugg....
- [5] Cytosurge AG. (7/9/19). "Press Release: Olympus Europe and Cytosurge Partner to Enhance Pharma Drug Development and Single Cell Research". Zurich / Glattbrugg & Hamburg....
- [6] Cytosurge AG. (6/29/18). "Press Release: Partnership between Bruker and Cytosurge – Enabling FluidFM Single Cell Experiments on the BioScope Resolve BioAFM". Zurich / Glattbrugg....
- [7] Bruker Corporation. (6/27/18). "Press Release: Bruker Introduces FluidFM on the BioScope Resolve BioAFM". Santa Barbara, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top